Gilead Sciences, Inc.
GILDNASDAQHealthcare● Active
$129.16
$-0.02(-0.02%)
Market Cap$160.4B
P/E Ratio—
52W High$157.29
52W Low$104.46
Gilead Sciences, Inc. (GILD) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GILD · as of 2026-06-08
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $10.61B | $11.57B | $7.26B | $6.38B | $6.52B |
| Net Receivables | $4.91B | $4.42B | $4.66B | $4.78B | $4.49B |
| Inventory | $4.37B | $1.71B | $1.79B | $1.51B | $1.62B |
| Total Current Assets | $19.89B | $19.17B | $16.09B | $14.44B | $14.77B |
| PP&E Net | $5.61B | $5.41B | $5.32B | $5.47B | $5.12B |
| Goodwill | $8.31B | $8.31B | $8.31B | $8.31B | $8.33B |
| Intangible Assets | $16.98B | $19.95B | $26.45B | $28.89B | $33.45B |
| Total Assets | $59.02B | $58.99B | $62.13B | $63.17B | $67.95B |
| Liabilities | |||||
| Short-Term Debt | $0.00B | $1.81B | $1.80B | $2.27B | $1.52B |
| Accounts Payable | $0.00B | $0.83B | $0.55B | $0.91B | $0.70B |
| Total Current Liabilities | $11.81B | $12.00B | $11.28B | $11.24B | $11.61B |
| Long-Term Debt | $24.59B | $24.90B | $23.19B | $22.96B | $25.18B |
| Total Liabilities | $36.41B | $39.75B | $39.38B | $41.96B | $46.89B |
| Stockholders Equity | |||||
| Retained Earnings | $0.00B | $11.50B | $16.30B | $15.69B | $16.32B |
| Total Stockholders Equity | $22.62B | $19.33B | $22.83B | $21.24B | $21.07B |
| Total Liab & Equity(computed) | $59.02B | $59.08B | $62.21B | $63.20B | $67.96B |
| Debt Summary | |||||
| Total Debt | $24.59B | $26.71B | $24.99B | $25.23B | $26.70B |
| Net Debt | $17.03B | $16.72B | $18.90B | $19.82B | $21.36B |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Gilead Sciences, Inc. data
About Gilead Sciences, Inc. (GILD) Balance Sheet
Gilead Sciences, Inc. (GILD) balance sheet shows total assets of $59.02B with cash of $10.61B. Total liabilities are $36.41B, total debt $24.59B, and stockholders equity $22.62B.
Frequently asked questions
GILD · 4 questionsGilead Sciences, Inc. has total debt of $24.59B with net debt of $17.03B.
GILD total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08